The Wall Street Journal5d agoneutral
Health Care Roundup: Market TalkFind insight on the deal between Hengrui Pharmaceuticals and Bristol Myers Squibb and more in the latest Market Talks covering the health care sector.
Actualités
Uniquement les titres à fort signal — événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
55last 24h
1682last 7d
314🟢 bullish (7d)
171🔴 bearish (7d)
136publishers
The Wall Street Journal5d agoneutral
Bristol-Myers Squibb and China’s Hengrui Pharma Forge Tie-UpU.S. pharma giant Bristol-Myers Squibb has struck a partnership and licensing deal with Chinese drugmaker Hengrui, in a deal that could worth more than $15 billion.
